The site consists of five fermentation "mini-factories" capable of concurrently producing our more than 13 currently scaled and future bio-fermented products
The recombinant nanoparticle-based rabies G protein vaccine is prepared using virus-like particle technology.
Global event to kick off as the post-covid era begins in earnest, with theme "beyond the pandemic, into a next wave"
Exclusive distribution agreement brings Point-Of-Care (POC) haematology diagnostics to new regions in the Middle East
Headwinds related to pricing pressures and rising raw material costs will result in some contraction in margins in Q4 FY22 and FY23
GE Healthcare and Elekta aim to meet the major need for radiotherapy solutions across both developed and developing markets
Macushield tablets assist with age-related macular degeneration, diabetic retinopathy and improves overall vision
All intellectual-property disputes related to the market entry of Alvotech’s AVT02 (adalimumab) in the U.S. and Europe are now resolved
New simplified structure and operational set-up supports Novartis strategy as a focused medicines company and is designed to power next phase of innovation, growth and productivity
Celerity Pharmaceuticals uses Biocon Biologics’ insulin drug substance to develop the product
Subscribe To Our Newsletter & Stay Updated
